In summary, preclinical and clinical evidence shows that 5-HT and BDNF have a bidirectional relationship, where the modification of one may affect the other, which can have a direct impact in the establishment of both depression symptoms and the therapeutic effects of antidepressants. This evidence concerns the gene BDNF and depressive disorder.